logo

LEADER SPOTLIGHT

Jed Litwiniuk, MHA

Chief Executive Officer

“We are focused on transforming cardiovascular care through innovation and science. Our teams, tools, and technologies support our R&D strategy, with a focus on value-added medicines and a simplified regulatory pathway to ensure efficient access for patients."

Jed CEO's photo

Our mission

We are dedicated to addressing unmet medical needs in cardiovascular health by transforming and enhancing existing medications. Our mission is to improve patient outcomes by delivering Value-Added Medications in convenient dosage forms that benefit patients, healthcare providers, and payors alike.

We focus on adding value to medicines with well established clinical history by optimizing their formulation a

Aligning science and experience to change the world

Jed Litwiniuk, MHA

Jed Litwiniuk, MHA

Chief Executive Officer
Uwe Tigör, MD

Uwe Tigör, MD

Chief Medical Officer
Dawid Chabowski, PhD

Dawid Chabowski, PhD

Science & Operational Manager
Pascal St-Laurent

Pascal St-Laurent

Pharmaceutical Development Consultant
Anthony Grenier

Anthony Grenier

Tech Transfer & CMC Consultant
Len S. Smith

Len S. Smith

Chief IP Counsel

Scientific Advisory Board

Juan Kaski, Professor of Medicine

Juan Kaski, Professor of Medicine

Medical Advisor
Michael Weber, Professor of Medicine

Michael Weber, Professor of Medicine

Cardiology Advisor
Giora Davidai, MD

Giora Davidai, MD

Medical Advisor
TomaszH. Zastawny, PhD, DSc

TomaszH. Zastawny, PhD, DSc

Strategic Advisor

We Care About Your Privacy

Auxilius Pharma uses cookies to improve and customize your experience on our website. By selecting 'Accept', you allow Auxilius Pharma to gather and use information about your interactions with our site to provide personalized content and enhance your digital experience. For more details on how we use these technologies, please review our Privacy Policy.